[Polyvalent immunoglobins in general pediatrics: what place, what risk, and what cost?]

Arch Pediatr. 1999:6 Suppl 2:397s-399s. doi: 10.1016/s0929-693x(99)80480-1.
[Article in French]
No abstract available

MeSH terms

  • Child
  • Costs and Cost Analysis
  • France
  • Humans
  • Immunoglobulins, Intravenous / adverse effects
  • Immunoglobulins, Intravenous / economics
  • Immunoglobulins, Intravenous / therapeutic use*
  • Immunologic Deficiency Syndromes / therapy
  • Mucocutaneous Lymph Node Syndrome / therapy
  • Pediatrics
  • Polyradiculoneuropathy / therapy
  • Purpura, Thrombocytopenic, Idiopathic / therapy

Substances

  • Immunoglobulins, Intravenous